Incidence and Factors Associated With Androgenetic Alopecia Among Transgender and Gender-Diverse Patients Treated With Masculinizing Hormone Therapy.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33566078.
- Also identified by DOI 10.1001/jamadermatol.2020.5475 and PMC identifier 7876619.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines the proportion of transgender and gender-diverse individuals patients receiving masculinizing hormone therapy who developed androgenetic alopecia.
Medical subject headings
- Alopecia
- Hormone Replacement Therapy
- Transgender Persons